FDA Inspection 988679 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on October 10, 2016 in Rexburg, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 10, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rexburg, ID (United States)